Key result
Dazoxiben effectively inhibited thromboxane synthetase and increased 6-keto-PGF1 alpha formation by over 100%, but had a weaker effect on platelet reactivity than acetylsalicylic acid.
Why the study?
Does dazoxiben or acetylsalicylic acid affect platelet function and prostaglandin metabolism in men?
RCT (n=24)
Does dazoxiben or acetylsalicylic acid affect platelet function and prostaglandin metabolism in men?
Dazoxiben is a selective thromboxane synthetase inhibitor that increases prostacyclin metabolite levels but has a weaker antiplatelet effect than acetylsalicylic acid.
Answers are grounded in this paper and cite their sources.
Dazoxiben may provide weaker platelet inhibition than aspirin; leaves open whether selective thromboxane synthetase inhibition confers clinical benefit.
Twenty-four men received either placebo, 0.1 g of the thromboxane synthetase inhibitor dazoxiben, 0.25 or 1.0 g of acetylsalicylic acid (ASA). Dazoxiben reduced the maximal rate of collagen-induced platelet aggregation, but less than did ASA. ASA abolished secondary, ADP-induced aggregation, dazoxiben not. Both drugs prolonged the bleeding-time. Plasma thromboxane B2 (TxB2) levels did not change significantly after dazoxiben, whereas the prostacyclin metabolite 6-keto-PGF1 alpha rose. The larger dose of ASA reduced both TxB2 and 6-keto-PGF1 alpha in plasma. Whole blood was allowed to clot in order to estimate prostaglandin metabolism. Both drugs prevented thromboxane production effectively. Formation of 6-keto-PGF1 alpha decreased by 95 per cent after ASA but was more than doubled after dazoxiben. Dazoxiben is a selective and effective thromboxane synthetase inhibitor, but has a weaker effect on platelet reactivity than ASA, possibly because endoperoxide formation is not prevented.
No takes yet. Share an insight, caveat, or question.
Dale et al. (1983) reported an RCT. Dazoxiben and Acetylsalicylic Acid vs. Placebo was evaluated on Platelet function and prostaglandin metabolism. Dazoxiben effectively inhibited thromboxane synthetase and increased 6-keto-PGF1 alpha formation by over 100%, but had a weaker effect on platelet reactivity than acetylsalicylic acid.
Synapse has enriched 10 related papers. Consider them for comparative context: